-
Daiichi Sankyo2021-05-07 09:29:00Datopotamab Deruxtecan Late-Breaking Data at ESMO Breast Shows Promising Preliminary Response and Disease
-
Daiichi Sankyo2021-02-22 13:14:52Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D